Henning Beck-Nielsen
Overview
Explore the profile of Henning Beck-Nielsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
209
Citations
5172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kristensen F, Domazet S, Nielsen J, Stidsen J, Hojlund K, Beck-Nielsen H, et al.
Diabetologia
. 2024 Dec;
68(3):576-587.
PMID: 39663235
Aims/hypothesis: A better understanding of the mechanisms underlying an elevated infection risk in individuals with type 2 diabetes is needed to guide risk stratification and prevention. We investigated the risk...
2.
Kristensen F, Nicolaisen S, Nielsen J, Christensen D, Hojlund K, Beck-Nielsen H, et al.
Clin Epidemiol
. 2024 Sep;
16:641-656.
PMID: 39345299
Purpose: This paper provides an overview of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort and biobank, including baseline characteristics of participants enrolled up to 2023,...
3.
Brosen J, Agesen R, Alibegovic A, Andersen H, Beck-Nielsen H, Gustenhoff P, et al.
J Diabetes Sci Technol
. 2023 Sep;
19(2):390-399.
PMID: 37671755
Aim: Comparing continuous glucose monitoring (CGM)-recorded metrics during treatment with insulin degludec (IDeg) versus insulin glargine U100 (IGlar-100) in people with type 1 diabetes (T1D) and recurrent nocturnal severe hypoglycemia....
4.
Gram-Kampmann E, Olesen T, Hansen C, Hugger M, Jensen J, Handberg A, et al.
Cardiovasc Diabetol
. 2023 Aug;
22(1):212.
PMID: 37592243
Background: While a low-carbohydrate diet (LCD) reduces HbA1c in patients with type 2 diabetes (T2D), the associated high intake of fat may adversely affect cardiovascular risk factors. To address this,...
5.
Kristensen F, Christensen D, Callaghan B, Stidsen J, Nielsen J, Hojlund K, et al.
Diabetes Care
. 2023 Jun;
46(8):1546-1555.
PMID: 37335990
Objective: Metabolic syndrome components may cumulatively increase the risk of diabetic polyneuropathy (DPN) in type 2 diabetes mellitus (T2DM) patients, driven by insulin resistance and hyperinsulinemia. We investigated the prevalence...
6.
Thuesen A, Jensen R, Maagensen H, Kristiansen M, Sorensen H, Vaag A, et al.
Mol Genet Metab Rep
. 2023 Apr;
35:100972.
PMID: 37008541
Background: Functionally disruptive variants in the glucokinase gene () cause a form of mild non-progressive hyperglycemia, which does not require pharmacological treatment. A substantial proportion of patients with type 2...
7.
Gedebjerg A, Bjerre M, Kjaergaard A, Nielsen J, Rungby J, Brandslund I, et al.
Diabetes Care
. 2023 Mar;
46(5):1037-1045.
PMID: 36930691
Objective: We investigated the relationship between hs-CRP, a marker of low-grade inflammation, alone or in combination with C-peptide, a marker of hyperinsulinemia/insulin resistance, and risk for cardiovascular events (CVEs) and...
8.
Brosen J, Agesen R, Kristensen P, Alibegovic A, Andersen H, Beck-Nielsen H, et al.
Diabetes Obes Metab
. 2023 Feb;
25(6):1557-1565.
PMID: 36749303
Aim: To compare nocturnal glucose profiles according to hourly plasma glucose measurements during treatment with insulin degludec and insulin glargine U100 in a cohort of people with type 1 diabetes...
9.
Hansen C, Gram-Kampmann E, Hansen J, Hugger M, Madsen B, Jensen J, et al.
Ann Intern Med
. 2022 Dec;
176(1):10-21.
PMID: 36508737
Background: It remains unclear if a low-carbohydrate, high-fat (LCHF) diet is a possible treatment strategy for type 2 diabetes mellitus (T2DM), and the effect on nonalcoholic fatty liver disease (NAFLD)...
10.
Gjesing A, Engelbrechtsen L, Thuesen A, Have C, Hollensted M, Grarup N, et al.
Diabetes Res Clin Pract
. 2022 Nov;
194:110159.
PMID: 36400171
Aims: Rare variants in the glucokinase gene (GCK) cause Maturity-Onset Diabetes of the Young (MODY2/GCK-MODY). We investigated the prevalence of GCK variants, phenotypic characteristics, micro- and macrovascular disease at baseline...